Search Login Register

Epoprostenol (Prostacyclin) Summary

Description: A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).

Also Known As: Prostacyclin; PGI2; Epoprostenol Sodium; Flolan; PGX Show All >>

Networked: 4437 relevant articles (284 outcomes, 503 trials/studies) for this Drug

Key Diseases for which Epoprostenol is Relevant

  1. Pulmonary Hypertension (Ayerza Syndrome) : 56 outcomes 45 studies in 446 results
  2. Ischemia : 15 outcomes 17 studies in 223 results
  3. Thrombosis (Thrombus) : 14 outcomes 8 studies in 233 results
  4. Anoxia (Hypoxia) : 11 outcomes 14 studies in 193 results
  5. Reperfusion Injury : 11 outcomes 10 studies in 73 results
Show All >>

Drugs Related to Epoprostenol

  1. Epoprostenol (Prostacyclin)
  2. Iloprost (Ventavis)
  3. Nitric Oxide (Nitrogen Monoxide)
  4. beraprost
  5. Aspirin (Acetylsalicylic Acid)
  6. Idiopathic pulmonary hypertension
  7. Dinoprostone (PGE2)
  8. Thromboxane A2 (A2, Thromboxane)
  9. Alprostadil (Muse)
  10. Vasodilator Agents (Vasodilators)
Show All >>

Therapies Related to Epoprostenol

  1. Transplantation (Transplant Recipients)
  2. Catheters
  3. Warm Ischemia
  4. Liver Transplantation
  5. Artificial Respiration (Mechanical Ventilation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.